Article
Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review.
International journal of clinical pharmacy - 1 Jun 2022
Fahmi Amr Mohamed, Elewa Hazem, El Jilany Islam
Abstract excerpt
Background For decades, vitamin K antagonists and specifically warfarin, have been the sole agents used orally to manage thromboembolic conditions, including stroke and venous thromboembolism (VTE). Several factors lead to warfarin dose variability, including genetic and non-genetic factors which made warfarin management challenging especially at the initiation phase. To overcome the challenges with warfarin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.